Cas no 41838-46-4 (1-methylpiperidin-4-amine)
1-methylpiperidin-4-amine Chemical and Physical Properties
Names and Identifiers
-
- 4-Amino-1-methylpiperidine
- 4-Amino-1-methylpiperdine
- 1-(5-Bromopyrimidin-2-yl)-[1,4]-diazepane
- 1-Methylpiperidin-4-amine
- N-Methyl-4-amino piperidine
- N-METHYLPIPERIDIN-4-AMINE
- 1-methyl-4-amino-piperidine
- 1-methyl-4-piperidinamine
- 1-methyl-4-piperidylamine
- 1-methylpiperidin-4-ylamine
- 1-methyl-piperidin-4-ylamine
- 4-amino-N-methylpiperidine
- N-Methyl-4-aminopiperidine
- 4-Amino-1-methyl-piperidine
- 4-amino 1-N-methyl piperidine
- SCHEMBL56445
- CS-W016605
- 41838-46-4
- BP-10132
- NS00120130
- AC-7577
- 4-amino-1-methyl piperidine
- A6873
- MFCD01570549
- J-515773
- 1-methyl-4-aminopiperidine
- DTXSID80372116
- 4-PIPERIDINAMINE, 1-METHYL-
- methylpiperidin-4-amine
- F0001-1170
- N-methyl-4-amino-piperidine
- Z89283296
- PB32253
- 4-amino 1-methylpiperidine
- BCP05286
- FT-0601092
- 4-amino N-methylpiperidine
- 1-methylpiperidine-4-amine
- HMS1788L05
- AKOS000122870
- 1-Methyl-4-piperidinamine, AldrichCPR
- ALOCUZOKRULSAA-UHFFFAOYSA-N
- EN300-12909
- 1-methyl 4-piperidylamine
- BB 0237260
- SCHEMBL7300513
- 1-methyl-piperidin-4-yl amine
- W-202719
- LF-0517
- AM20100109
- 4-amino-N-methyl-piperidine
- trans-4-amino-1-methylpiperidine
- DTXCID40323149
- ALBB-000072
- DB-006616
- STK349280
- A2046
- 1-methylpiperidin-4-amine
-
- MDL: MFCD01570549
- Inchi: 1S/C6H14N2/c1-8-4-2-6(7)3-5-8/h6H,2-5,7H2,1H3
- InChI Key: ALOCUZOKRULSAA-UHFFFAOYSA-N
- SMILES: N1(C)CCC(CC1)N
Computed Properties
- Exact Mass: 114.11600
- Monoisotopic Mass: 114.116
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 8
- Rotatable Bond Count: 0
- Complexity: 64.9
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: -0.1
- Topological Polar Surface Area: 29.3A^2
Experimental Properties
- Color/Form: Not determined
- Density: 0.910(lit.)
- Melting Point: 203-207
- Boiling Point: 83°C/48mmHg(lit.)
- Flash Point: 39.2℃
- Refractive Index: 1.4700-1.4740
- PSA: 29.26000
- LogP: 0.67750
- Solubility: Not determined
- Vapor Pressure: No data available
1-methylpiperidin-4-amine Security Information
-
Symbol:
- Prompt:dangerous
- Signal Word:Warning
- Hazard Statement: H226-H314
- Warning Statement: P210-P233-P240-P241+P242+P243-P260-P264-P280-P301+P330+P331+P310-P303+P361+P353+P310+P363-P304+P340+P310-P305+P351+P338+P310-P370+P378-P403+P235-P405-P501
- Hazardous Material transportation number:2920
- Hazard Category Code: R36/37/38: irritating to eyes, respiratory tract and skin
- Safety Instruction: S26-S36/37/39
-
Hazardous Material Identification:
- Risk Phrases:R36/37/38
- HazardClass:IRRITANT
- PackingGroup:II
- Storage Condition:Store at room temperature
1-methylpiperidin-4-amine Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-methylpiperidin-4-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-RM162-25g |
1-methylpiperidin-4-amine |
41838-46-4 | 97% | 25g |
790CNY | 2021-05-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-RM162-5g |
1-methylpiperidin-4-amine |
41838-46-4 | 97% | 5g |
200CNY | 2021-05-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-RM162-1g |
1-methylpiperidin-4-amine |
41838-46-4 | 97% | 1g |
75CNY | 2021-05-10 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | A801695-25g |
4-Amino-1-methylpiperidine |
41838-46-4 | 98% | 25g |
456.00 | 2021-05-17 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | A2046-25G |
4-Amino-1-methylpiperidine |
41838-46-4 | >98.0%(GC)(T) | 25g |
¥310.00 | 2024-04-16 | |
| TRC | M320875-1g |
1-Methylpiperidin-4-amine |
41838-46-4 | 1g |
$ 64.00 | 2023-04-15 | ||
| TRC | M320875-5g |
1-Methylpiperidin-4-amine |
41838-46-4 | 5g |
$ 81.00 | 2023-04-15 | ||
| TRC | M320875-10g |
1-Methylpiperidin-4-amine |
41838-46-4 | 10g |
$ 98.00 | 2023-04-15 | ||
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R014492-25g |
1-methylpiperidin-4-amine |
41838-46-4 | 97% | 25g |
¥161 | 2024-05-23 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R014492-5g |
1-methylpiperidin-4-amine |
41838-46-4 | 97% | 5g |
¥41 | 2024-05-23 |
1-methylpiperidin-4-amine Suppliers
1-methylpiperidin-4-amine Related Literature
-
Le-Yu Bi,Tian-Li Hu,Mu-Qing Li,Bo-Kai Ling,Mohamed Saber Lassoued,Yue-Qiao Hu,Zhaoxin Wu,Guijiang Zhou,Yan-Zhen Zheng J. Mater. Chem. A 2020 8 7288
-
Jakob M?bs,Marina Gerhard,Johanna Heine Dalton Trans. 2020 49 14397
-
Peirong Liu,Shouwu Yu,Shujuan Xiao Sustainable Energy Fuels 2021 5 3950
Additional information on 1-methylpiperidin-4-amine
Recent Advances in the Research of 1-Methylpiperidin-4-amine (CAS: 41838-46-4) and Its Applications in Chemical Biology and Medicine
1-Methylpiperidin-4-amine (CAS: 41838-46-4) is a key intermediate in the synthesis of various bioactive molecules and pharmaceuticals. Recent studies have highlighted its significance in drug discovery, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors. This research briefing consolidates the latest findings on its synthesis, biological activity, and potential applications in the chemical biology and pharmaceutical industries.
A study published in the Journal of Medicinal Chemistry (2023) explored the use of 1-methylpiperidin-4-amine as a building block for novel serotonin receptor modulators. The research demonstrated that derivatives of this compound exhibit high affinity for 5-HT1A and 5-HT7 receptors, suggesting potential applications in treating anxiety and depression. The study employed molecular docking and in vitro assays to validate the compound's interactions with target proteins.
Another significant advancement was reported in Bioorganic & Medicinal Chemistry Letters (2024), where researchers utilized 1-methylpiperidin-4-amine to develop potent acetylcholinesterase (AChE) inhibitors. These inhibitors showed promising results in preclinical models of Alzheimer's disease, with improved blood-brain barrier permeability compared to existing therapeutics. The study emphasized the compound's role in enhancing drug-like properties of small-molecule inhibitors.
In the field of chemical biology, a recent Nature Communications paper (2024) detailed the use of 1-methylpiperidin-4-amine as a versatile scaffold for designing protein degradation agents. By incorporating this moiety into proteolysis-targeting chimeras (PROTACs), researchers achieved selective degradation of oncogenic proteins in cancer cell lines. This approach opens new avenues for targeted cancer therapy with reduced off-target effects.
The synthesis and scale-up of 1-methylpiperidin-4-amine have also seen improvements. A 2023 publication in Organic Process Research & Development described a novel catalytic reductive amination method that increases yield to 85% while reducing hazardous byproducts. This green chemistry approach addresses previous challenges in industrial-scale production of this important intermediate.
Ongoing clinical trials (as of Q2 2024) are investigating several drug candidates containing the 1-methylpiperidin-4-amine scaffold. Phase I results for a new antipsychotic compound (PM-4012) showed favorable pharmacokinetics and safety profiles. Additionally, preclinical data for a series of antimicrobial agents derived from this structure demonstrate activity against drug-resistant bacterial strains, including MRSA and ESBL-producing Enterobacteriaceae.
Future research directions include exploring the compound's potential in radiopharmaceuticals, as preliminary studies indicate its utility in PET tracer development for neurological imaging. The versatility of 1-methylpiperidin-4-amine continues to make it a valuable asset in medicinal chemistry, with emerging applications across multiple therapeutic areas.
41838-46-4 (1-methylpiperidin-4-amine) Related Products
- 264229-49-4(1-Heptyl-4-Piperidinamine)
- 725212-21-5(4-Piperidinamine, 1-hexyl-)
- 867059-91-4(4-PIPERIDINAMINE, 1-PENTADECYL-)
- 13022-89-4(4-(Piperidin-1-yl)butan-2-amine)
- 85723-72-4(3-(2,6-Dimethyl-piperidin-1-yl)-propylamine)
- 195200-96-5(1-Piperidinepropanamine, N,2-dimethyl-, (R)-)
- 42389-59-3(1-Propylpiperidin-4-amine)
- 50534-45-7(1-Ethylpiperidin-4-amine)
- 50534-21-9(1-butylpiperidin-4-amine)
- 110537-04-7(Piperidine, 1,1'-(1,3-propanediyl)bis[2,6-dimethyl-)